Diagnostics criteria | Steps | OGTT | No. abnormal | Fasting mg/dl (mmol/l) | 1 H mg/dl (mmol/l) | 2 H mg/dl (mmol/l) | 3H mg/dl (mmol/l) |
---|---|---|---|---|---|---|---|
O′ Sullivan 1964 [49] | 2 | 100 g | ≥ 2 | 90 (5) | 165 (9.2) | 145 (8.1) | 125 (6.9) |
NDDG 1979 [50] | 2 | 100 g | ≥ 2 | 105 (5.8) | 190 (10.6) | 165 (9.2) | 145 (8.0) |
CC 1982 [51] | 2 | 100 g | ≥ 2 | 95 (5.3) | 180 (10) | 155 (8.6) | 140 (7.8) |
EASD 2012 [52] | 1 | 75 g | ≥ 1 | 108 (6) | – | 162 (9) | – |
ACOG [53] | 2 | 100 g | ≥ 2 | 95 (5.30 | 180 (10) | 155 (8.6) | 140 (7.8) |
ADIPS 1998 [54] | 1 | 75 g | ≥ 1 | 100 (5.5) | – | 144 (8.0) | – |
IADPSG 2010 [55] | 1 | 75 g | ≥ 2 | 92 (5.1) | 180 (10) | 153 (8.5) | – |
DIPSI [25] | 1 | 75 g | ≥ 1 | – | – | 140 (7.8) | – |
JDS [56] | 1 | 75 g | ≥ 2 | 126 (7) | – | 200 (11.1) | – |
China MOH [57] | 1 | 75 g | ≥ 1 | 92 (5.1) | 180 (10) | 153 (8.5) | – |
ICD-10 O24.4 (58) | 2 | 75 g | ≥ 1 | 92 (5.1) | 180 (10) | 153 (8.5) | – |
ADA 1997 [59] | 1 | 75 g | ≥ 1 | 126 (7) | – | 200 (11.1) | – |
ADA 2002 [37] | 1 | 75 g | ≥ 1 | 126 (7) | – | 200 (11.1) |  |
ADA 2003 [38] | 2 | 100 g | ≥ 2 | 95 (5.3) | 180 (10) | 155 (8.6) | 140 (7.8) |
ADA 2004 [39] | 2 | 100 g | ≥ 1 | 95 (5.3) | 180 (10) | 155 (8.6) | 140 (7.8) |
ADA 2011 [40] | 1 | 75 g | ≥ 1 | 92 (5.1) | – | – | – |
ADA 2012 [41] | 1 | 75 g | ≥ 1 | 92 (5.1) | 180 (10) | 153 (8.5) | – |
ADA 2014 [42] | 1 | 75 g | ≥ 1 | – | 180 (10) | 153 (8.5) | – |
WHO 1980 [43] | 1 | 75 g | ≥ 1 | 140 (7.8) | – | 200 (11.1) | – |
WHO 1998 [44] | 1 | 75 g | ≥ 1 | 126 (7) | – | 200 (10) | – |
WHO 1985 [45] | 1 | 75 g | ≥ 1 | – | – | 140 (7.8) | – |
WHO 1999 [44] | 1 | 75 g | ≥ 1 | 126 (7) | – | 140 (7.8) | – |
WHO 2006 [46] | 1 | 75 g | ≥ 1 | 126 (7) | 180 (10) | 200 (11.1) | – |
WHO 2013 [47] | 1 | 75 g | ≥ 1 | 92 (5.1) | 180 (10) | 153 (8.5) | – |
CDA 2008 [48] | 1 | 75 g | ≥ 2 | 95 (5.3) | 190 (10.6) | 160 (8.9) | – |